Hormone-Guided dosing may improve treatment for Hard-to-Control high blood pressure
NCT ID NCT06108427
First seen Mar 19, 2026 · Last updated Apr 29, 2026 · Updated 7 times
Summary
This study looks at whether using a hormone called renin to guide the dose of a specific blood pressure medicine (MRA) can improve treatment for people with primary aldosteronism, a condition that causes high blood pressure. About 58 adults with this condition will be split into two groups: one where doctors adjust medicine based on renin levels, and one where renin is not checked. The goal is to see if renin-guided dosing leads to better hormone control and fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital du Sacré-Coeur de Montréal
RECRUITINGMontreal, Quebec, H4J1C5, Canada
Contact
Contact
Conditions
Explore the condition pages connected to this study.